Last update 01 Nov 2024

ICM Biotech Australia Pty Ltd.

Private Company

Overview

Tags

Immune System Diseases
Skin and Musculoskeletal Diseases
AAV based gene therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Top 5 Drug TypeCount
AAV based gene therapy1
Top 5 TargetCount
NKX3-2(NK3 homeobox 2)1

Related

1
Drugs associated with ICM Biotech Australia Pty Ltd.
ICM-203
Target
NKX3-2
Mechanism
NKX3-2 modulators [+1]
Active Org.
ICM Biotech Australia Pty Ltd. [+2]
Originator Org.
ICM Co. Ltd.ICM Co. Ltd.
Active Indication
Osteoarthritis, Knee [+2]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with ICM Biotech Australia Pty Ltd.
NCT04875754 / RecruitingPhase 1/2
A Phase 1/2a, Double-Blind, Placebo-Controlled Single Dose Escalation Study of Intra-Articular ICM 203 in Subjects With Kellgren-Lawrence Grade 2 or Grade 3 Osteoarthritis of the Knee
100 Clinical Results associated with ICM Biotech Australia Pty Ltd.
Login to view more data
0 Patents (Medical) associated with ICM Biotech Australia Pty Ltd.
Login to view more data
100 Deals associated with ICM Biotech Australia Pty Ltd.
Login to view more data
100 Translational Medicine associated with ICM Biotech Australia Pty Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ICM-203
 ( NKX3-2 )		Osteoarthritis, Knee
More
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free